Home > National Drug Code (NDC) > Irinotecan Hydrochloride

Irinotecan Hydrochloride - 66758-048-01 - (Irinotecan Hydrochloride)

Alphabetical Index


Drug Information of Irinotecan Hydrochloride

Product NDC: 66758-048
Proprietary Name: Irinotecan Hydrochloride
Non Proprietary Name: Irinotecan Hydrochloride
Active Ingredient(s): 20    mg/mL & nbsp;   Irinotecan Hydrochloride
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Irinotecan Hydrochloride

Product NDC: 66758-048
Labeler Name: Sandoz Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA090137
Marketing Category: ANDA
Start Marketing Date: 20091130

Package Information of Irinotecan Hydrochloride

Package NDC: 66758-048-01
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (66758-048-01) > 2 mL in 1 VIAL, SINGLE-DOSE

NDC Information of Irinotecan Hydrochloride

NDC Code 66758-048-01
Proprietary Name Irinotecan Hydrochloride
Package Description 1 VIAL, SINGLE-DOSE in 1 CARTON (66758-048-01) > 2 mL in 1 VIAL, SINGLE-DOSE
Product NDC 66758-048
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Irinotecan Hydrochloride
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20091130
Marketing Category Name ANDA
Labeler Name Sandoz Inc
Substance Name IRINOTECAN HYDROCHLORIDE
Strength Number 20
Strength Unit mg/mL
Pharmaceutical Classes Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]

Complete Information of Irinotecan Hydrochloride


General Information